首页> 中文期刊> 《四川医学》 >160例良性发作性位置性眩晕抗焦虑治疗疗效分析

160例良性发作性位置性眩晕抗焦虑治疗疗效分析

             

摘要

Objective To investigate cause of anxiety in patients with benign paroxysmal positional vertigo(BPPV) and the therapeutic effectiveness of anti-anxiety therapy. Methods Into our hospital outpatient and inpatient 2008 ~ 2010 BPPV pa tients 160 cases, were randomly divided into two groups, anxiety group and control group, anti-anxiety group treatment of conven tions anti-vertigo(drugs and manual reduction) + droperidol melitracen seton treatment, Normal control group conventional treat ment of vertigo. Two groups of patients before treatment, treatment for 3 days, treatment for 10 days , respectively dizziness deter mination Scale and Hamilton Anxiety Scale. Results BPPV patients are often accompanied by anxiety or anxiety symptoms, targe ted for anti-anxiety treatment can help to improve symptoms in patients with vertigo. Conclusion BPPV patients often accompa nied by symptoms of anxiety or anxiety, targeted therapy for anxiety can help to improve the symptoms in patients with vertigo.%目的 探讨特发性良性发作性位置性眩晕患者的焦虑原因及其抗焦虑治疗疗效.方法 纳入我院2008 ~2010年间门诊及住院的特发性良性发作性位置性眩晕患者160例,随机分为抗焦虑组和对照组,抗焦虑组进行常规眩晕治疗(药物及手法复位)+氟哌塞顿美利曲辛治疗,对照组进行常规眩晕治疗.两组患者在初诊时,治疗第3天,第10天分别进行眩晕量表及汉密尔顿焦虑量表测定.结果 抗焦虑组汉密尔顿焦虑量表分值明显低于对照组,眩晕症状改善明显优于对照组.结论 特发性良性发作性位置性眩晕患者往往伴随有焦虑情绪或者焦虑症状,针对性进行抗焦虑治疗有益于改善患者眩晕症状.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号